Genetic epidemiology of skeletal system aging in apparently healthy human population

Mechanisms of Ageing and Development

Volumn 126, Issue 2, 2005, Pages 269-279

  Livshits, Gregory ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

BMD; Bone mass and size; Candidate genes; Genetic effects; Osteoarthritis

Indexed keywords

COLLAGEN TYPE 1; CYTOKINE; ESTROGEN RECEPTOR ALPHA; GROWTH FACTOR; PYROPHOSPHATE;

AGING; BONE AGE; BONE MASS; BONE METABOLISM; BONE REMODELING; CONFERENCE PAPER; GENETIC ANALYSIS; GENETIC EPIDEMIOLOGY; HEREDITY; HUMAN; OSTEOARTHRITIS; OSTEOLYSIS; PHENOTYPE; PRIORITY JOURNAL;

AGE FACTORS; AGING; BIOLOGICAL TRANSPORT; BONE AND BONES; BONE REMODELING; CARTILAGE; COHORT STUDIES; COLLAGEN TYPE I; DIPHOSPHATES; ESTROGEN RECEPTOR ALPHA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LIKELIHOOD FUNCTIONS; LINKAGE (GENETICS); LINKAGE DISEQUILIBRIUM; MALE; MODELS, BIOLOGICAL; OSTEOARTHRITIS; OSTEOPOROSIS; PEDIGREE; PHENOTYPE; RISK FACTORS; STATISTICS; TIME FACTORS;

EID: 11144333675     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mad.2004.08.020     Document Type: Conference Paper

References (57)

1. G.R. Abecasis, L.R. Cardon, and W.O. Cookson A general test of association for quantitative traits in nuclear families Am. J. Hum. Genet. 66 2000 279 292
2. A. Boskey Matrix proteins and mineralization: an overview Connect. Tissue Res. 35 1996 357 363
3. N. Bucay, I. Sarosi, C.R. Dunstan, S. Morony, and J. Tarpley Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification Genes Dev. 12 1998 1260 1268
4. A.J. Carr Beyond disability: measuring the social and personal consequences of osteoarthritis Osteoarthritis Cartilage 7 1999 230 238
5. H. Chagraoui, M. Tulliez, T. Smayra, E. Komura, S. Giraudier, T. Yun, N. Lassan, W. Vainchenker, and F. Wendling Stimulation of osteoprotegerin production is responsible for osteosclerosis in mice over expressing TPO Blood 101 2003 2983 2989
6. Crews, D.E., Gerber, L.M., 1994. Chronic degenerative diseases in aging. In: Crews, D.E., Garruto, R.M. (Eds.), Biological Anthropology and Aging: Perspectives on Human Variation Over the Life Span. Oxford, New York, pp. 154-181.
7. D.D. Dean, J. Martel-Pelletier, J.P. Pelletier, D.S. Howell, and J.F. Woessner Jr. Evidence for metalloprotease and metalloprotease inhibitors imbalance in human osteoarthritic cartilage J. Clin. Invest. 84 1989 678 685
8. V. De Leo, A. Ditto, A. Marca, D. Lanzetta, C. Massafra, and G. Morgante Bone mineral density and biochemical markers of bone turnover in peri-and postmenopausal women Calicf. Tissue Int. 66 2000 263 267
9. D.R. Edwards, G. Murphy, J.J. Reynolds, S.E. Whitham, A.L.P. Docherty, and P. Angel Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor EMBO J. 6 1987 1899 1904
10. M.J. Elders The increasing impact of arthritis on public health J. Rheumatol. Suppl. 22 2000 1509 1513
11. D.T. Felson, J.J. Anderson, A. Naimark, W. Kannel, and R.F. Meenan The prevalence of chondrocalcinosis in the elderly and its assocociation with knee osteoarthritis: The Framingham Study J. Rheumatol. 16 1989 1241 1245
12. H. Fleish Diphosphonates: history and mechanical action Met. Bone Dis. Relat. Res. 3 1981 279 281
13. M. Gunther, H.D. Haubeck, E. van de Leur, J. Blaser, S. Bender, and I. Gutgemann TGFβ1 regulates tissue inhibitor of metalloproteinase-1 expression in differentiated human articular chondrocytes Arthritis Rheum. 37 1994 395 405
14. L. Hessle, K.A. Johnson, H.C. Anderson, S. Narisawa, and A. Sali Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization Proc. Natl. Acad. Sci. U.S.A. 99 2002 9445 9454
15. J. Hirose, L.M. Ryan, and I. Masuda Up-regulated expression of cartilage intermediate-layer protein and ANK in articular hyaline cartilage from patients with calcium pyrophosphate dihydrate crystal deposition disease Arthritis Rheum. 46 2002 3218 3247
16. A.M. Ho, M.D. Johnson, and D.M. Kingsley Role of the mouse ank gene in control of tissue calcification and arthritis Science 289 2000 265 270
17. L.C. Hofbauer, and A.E. Heufelder Role of receptor activator of nuclear factor kB ligand and osteoprotegerin in bone cell biology J. Mol. Med. 79 2001 243 253
18. L.C. Hofbauer, F. Gori, B.L. Riggs, D.L. Lacey, C.R. Dunstan, T.C. Spelsberg, and S. Khosla Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis Endocrinology 140 1999 4382 4389
19. M.C. Horowitz, Y. Xi, K. Wilson, and M.A. Kacena Control of osteoclastogenesis and bone resorption by members of the TNF family of receptors and ligands Cytokine Growth Factor Rev. 2 2001 9 18
20. S. Horvath, X. Xu, and N.M. Laird The family-based association test method: strategies for studying general genotype-phenotype associations Eur. J. Human Gen. 9 2001 301 306
21. D. Karasik, E. Ginsburg, G. Livshits, and E. Kobyliansky Evidence on major gene control of cortical bone loss in human populations Genet. Epidem. 19 2000 410 421
22. J.H. Kellgren, and J.S. Lawrence Atlas of Standard Radiographs: The Epidemiology of Chronic Rheumatism, vol. 2 1963 Blackwell Scientific Publications Oxford, UK
23. S. Khosla, E.J. Atkinson, L.J. Melton III, and B.L. Riggs Effects of age and estrogen status on serum parathyroid hormone levels and biochemical markers of bone turnover in women: population-based study J. Clin. Endocrinol. Metab. 82 1997 1522 1527
24. S. Khosla The OPG/RANKL/RANK system: minireview Endocrinology 42 2001 5050 5055
25. G.M. Kiebzak Age-related bone changes Exp. Geront. 26 1991 171 187
26. Y.Y. Kong, H. Yoshida, I. Sarosi, H.L. Tan, and F. Timms OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis Nature 397 1999 315 323
27. J. Li, I. Sarosi, X.Q. Yan, S. Morony, and C. Capparelli RANK is the intrinsic hematopoietic cell surface receptor that control osteoclastogenesis and regulation of bone mass and calcium metabolism Proc. Natl. Acad. Sci. U.S.A. 97 2000 1566 1571
28. G. Livshits, K. Yakovenko, and E. Kobyliansky Quantitative genetic analysis of circulating levels of biochemical markers of bone formation Am. J. Med. Genet. 94 2000 324 331
29. G. Livshits, D. Karasik, and E. Kobyliansky Complex segregation analysis of the radiographic phalanges bone mineral density and their age-related changes J. Bone Miner. Res. 17 2002 152 161
30. G. Livshits, L. Kalichman, Z. Cohen, and E. Kobyliansky Mode of inheritance of hand osteoarthritis in ethnically homogeneous pedigrees Hum. Biol. 74 2002 849 860
31. G. Livshits, K. Yakovenko, and E. Kobyliansky Quantitative genetic study of radiographic hand bone size and geometry Bone 32 2003 191 198
32. G. Livshits, I. Pantsulaia, S. Trofimov, and E. Kobyliansky Genetic variation of circulating leptin is involved in genetic variation of hand bone size and geometry Osteoporos. Int. 14 2003 476 483
33. G. Livshits, K. Yakovenko, and M. Seibel Substantial genetic effects involved in determination of circulating levels of calciotropic hormones in human pedigrees Biochem. Genet. 41 2003 269 289
34. G. Livshits, I. Pantsulaia, S. Trofimov, and E. Kobyliansky Genetic epidemiology of circulating cytokines involved in osteoclastogenesis J. Med. Genet. 41 e76 2004 1 5
35. M. Lotz, F. Rosen, G. McCabe, J. Quach, and F. Vlanco Interleukin 1 beta suppresses transforming growth factor-induced inorganic pyrophosphate (PPi) production and expression of the PPi-generating enzyme PC-1 in human chondrocytes Proc. Natl. Acad. Sci. U.S.A. 92 1995 10364 10372
36. Y.L. Ma, R.L. Cain, D.L. Halladay, X. Yang, Q. Zeng, R.R. Miles, S. Chandrasekhar, T.J. Martin, and J.E. Onyia Catabolic effects of continuous human PTH (1-38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-association bone formation Endocrinology 142 2001 4047 4054
37. I. Malkin, D. Karasik, G. Livshits, and E. Kobyliansky Modeling of age-related bone loss using cross-sectional data Ann. Hum. Biol. 29 2002 256 270
38. I. Malkin, E. Ginsburg, and R.C. Elston Increase in power of transmission disequilibrium tests for quantitative traits Genet. Epidemiol. 23 2002 234 244
39. Malkin, I., Dahm, S., Suk, A., Kobyliansky, E., Toliat, M., Ruf, N., Luft, F.C., Livshits, G., Nurnberg, P. Association of ANKH gene polymorphisms with radiographic hand bone size and geometry in a Chuvasha population. Bone (in press).
40. P. Nurnberg, H. Thiele, D. Chandler, W. Hohne, M.L. Cunningham, H. Ritter, G. Leschik, K. Uhlmann, C. Mischung, K. Harrop, J. Goldblatt, Z.U. Borochowitz, D. Kotzot, F. Westermann, S. Mundlos, H.S. Braun, N. Laing, and S. Tonschert Heterozygous mutations in ANKH, the human ortholog of the mouse progressive ankylosis gene, result in craniometaphyseal dysplasia Nat. Genet. 28 2001 37 41
41. I. Pantsulaia, S. Trofimov, E. Kobyliansky, and G. Livshits Pedigree-based quantitative genetic analysis of interindividual variation in circulating levels of IGFBP-3 J. Bone Miner. Metab. 20 2002 156 163
42. I. Pantsulaia, S. Trofimov, E. Kobyliansky, and G. Livshits Genetic and environmental influences on IL-6 and TNF-alpha plasma levels in apparently healthy general population Cytokine 19 2002 138 146
43. Pantsulaia, I., Malkin, I., Trofimov, S., Kobyliansky, E., Livshits, G., 2004a. Genetic regulation of the variation of circulating variation of insulin-like growth factors and leptin in human pedigrees. (submitted for publication).
44. I. Pantsulaia, S. Trofimov, L. Kalichman, E. Kobyliansky, and G. Livshits The contribution of familial resemblance to variation in circulatory levels of tissue inhibitors of metalloproteinases and transforming growth factor β1 Calcif. Tissue Int. 74 2004 47 54
45. M. Peacock, C.H. Turner, M.J. Econs, and T. Foroud Genetics of osteoporosis Endocr. Rev. 23 2002 303 326
46. J.P. Pelletier, F. Mineau, M.P. Faure, and J. Martel-Pelletier Imbalance between the mechanisms of activation and inhibition (TIMP) of metalloproteases in early lesions of experimental osteoarthritis Arthritis Rheum. 33 1990 1466 1476
47. A. Pendleton, M.D. Johnson, A. Hughes, K.A. Gurley, A.M. Ho, M. Doherty, J. Dixey, P. Gillet, D. Loeuille, R. McGrath, A. Reginato, R. Shiang, G. Wright, P. Netter, C. Williams, and D.M. Kingsley Mutations in ANKH cause chondrocalcinosis Am. J. Hum. Genet. 71 2002 933 940
48. C.C. Plato, K.M. Fox, and J.D. Tobin Skeletal changes in human aging DE. Crews RM. Garruto Biological Anthropology and Aging 1994 Oxford University Press New York 272 300
49. R. Rizzoli, J.P. Bonjour, and S.L. Ferrari Osteoporosis, genetics and hormones J. Mol. Endocrinol. 26 2001 79 94
50. F. Ross, and S. Teitelbaum Osteoclast biology M.R. Feldman D. Kelsey Osteoporosis 2001 J. Academic Press
51. R. Sapir-Koren, G. Livshits, and E. Kobyliansky Association and linkage disequilibrium analysis suggest genetic effects of estrogen receptor α and Collagen IA1 genes on bone mineral density in Caucasian women Calcif. Tissue Int. 72 2003 643 650
52. R. Sapir-Koren, G. Livshits, and E. Kobyliansky Genetic effect of estrogen receptor α (alpha) and collagen IA1 genes on the relationships of PTH and 25(OH)D with bone mineral density in Caucasian women Metabolism 52 2003 1129 1135
53. M. Shinmei, Y. Okada, K. Masuda, M. Naramatsu, T. Kikuchi, M. Harigai, and Y. Shimonura The mechanism of cartilage degradation in osteoarthritic joints Sem. Arthritis Rheum. 119 1990 16 20
54. T.D. Spector, and A.J. MacGregor Risk factors for osteoarthritis: genetics Osteoarthritis Cartilage 12 Suppl. A 2004 S39 S44
55. R.K. Studer, E. Levicoff, H. Georfescu, L. Miller, D. Jaffurs, and C.H. Evans Nitric oxide inhibits chondrocyte response to IGF-1: inhibition of IGF-Irβ tyrosine phosphorylation Am. J. Physiol. Cell Physiol. 279 2000 961 969
56. R.A. Terkeltaub, K. Johnson, D. Rohnow, R. Goomer, D. Burton, and L.J. Deftos Bone morphogenetic proteins and bFGF exert opposing regulatory effects on PTHrP expression and inorganic pyrophosphate elaboration in immortalized murine endochondral hypertrophic chondrocytes (MCT cells) J. Bone Miner. Res. 13 1998 931 941
57. A.F. Wright, T.E. Cawston, and B.I. Hazleman TGF-β stimulates the production of the tissue inhibitor of metalloproteinases (TIMP) by human synovial and skin fibroblasts Biochem. Biophys. Acta 1093 1991 207 210